Apparatus and method for suspending a uterus

Information

  • Patent Grant
  • 9339362
  • Patent Number
    9,339,362
  • Date Filed
    Monday, January 3, 2011
    13 years ago
  • Date Issued
    Tuesday, May 17, 2016
    8 years ago
Abstract
An inter-vaginal device for performing a uterine suspension includes a rigid body for manipulating the uterus and implanting a suspension member, such as a mesh, for securing the uterus to an anchoring site (e.g., into a pelvic muscle or ligament). In one embodiment, a method includes inserting at least a portion of a uterine suspension member through an anterior or posterior vaginal incision. An end of the suspension member is anchored to a selected portion of a pelvic tissue. At least a portion of the suspension member is attached to a vaginal apex. A uterine manipulator is advanced in a direction toward the selected portion of the pelvic tissue such that at least a portion of a uterus is moved upward.
Description
BACKGROUND

The present invention relates generally to the field of medical devices, and in particular to an apparatus and method for suspending a uterus of a human or animal subject.


Many women with uterine prolapse would like for their condition to be surgically corrected, but avoid or delay undergoing an operation because they wish to avoid hysterectomy. The potential reasons for avoiding hysterectomy vary widely including plans for future childbearing, concern about the invasiveness of the procedure or the difficulty of the recuperation, or fear of diminished sexual function. Some women are simply reluctant to “give up” this part of their body so closely associated with their reproductive health, childbearing, and femininity.


Uterine prolapse can be effectively treated without hysterectomy, with low morbidity and high rates of patient satisfaction. A properly performed uterine suspension surgery often results in a significantly better anatomic outcome than hysterectomy. Yet, many hysterectomy procedures are performed for pelvic prolapse. One reason why most patients remain unaware of the uterine-sparing option is because with the exception of a few dedicated sub-specialists, most surgeons receive no training in these techniques. In addition, known techniques and equipment can be difficult and require involved specialized training that many general practitioners have not undertaken.


Thus a need exists for an improved apparatus and method for providing a minimally invasive hysteropexy that can be incorporated into mainstream gynecologic practice.


SUMMARY OF THE INVENTION

An apparatus, method and kit for performing a uterine suspension procedure are disclosed herein. In one embodiment, an inter-vaginal device for performing a uterine suspension includes a rigid body for manipulating the uterus and implanting a suspension member, such as a mesh, for securing the uterus to an anchoring site (e.g., into a pelvic muscle or ligament). In another embodiment, a method includes inserting at least a portion of a uterine suspension member through an anterior or posterior vaginal incision. An end of the suspension member is anchored to a selected portion of a pelvic tissue with anchoring methods that may include tying off with sutures, or directly affixing the suspension member to the pelvic tissue with, for example, self-affixing mesh arms. At least a portion of the suspension member can be attached to a vaginal apex or adjacent to the vaginal apex to further facilitate scarring. A uterine manipulator can be advanced in a direction toward the selected portion of the pelvic tissue such that at least a portion of a uterus is moved upward.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustration of various components that can be used in a method according to an embodiment of the invention.



FIG. 2 is a side perspective view of a device for performing a uterine suspension and a uterine suspension member according to an embodiment of the invention.



FIG. 3 is a front pictorial representation of a placement of a suspension member around a uterus using the device of FIG. 2.



FIG. 4 is a flowchart illustrating a method according to an embodiment of the invention.



FIG. 5 is a flowchart illustrating a method according to another embodiment of the invention.





DETAILED DESCRIPTION

The invention may be understood more readily by reference to the following detailed description of the invention taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Also, as used in the specification including the appended claims, the singular forms “a,” “an,” and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another embodiment.


In some embodiments, the invention includes a device for performing a uterine suspension comprising a substantially rigid body having a handle at a distal end thereof; a lumen through the substantially rigid body for housing sutures of a suspension member; and a uterine manipulator at a proximal end thereof. The uterine manipulator can further include a prong for insertion into the uterus; a tenaculum clip for securing the uterine manipulator to the cervix; and a pair of wings for aiding in securing the suspension member to the vagina. Optionally, the uterine suspension device can be included in a kit, along with a mesh or graft for a cystocele and/or a rectocele augmentation.


In another embodiment the invention includes a method of performing a uterine suspension. The method can include the steps of making an anterior or posterior vaginal incision; palpating ischial spines bilaterally; inserting the suspension member through the vaginal incision; placing suspension sutures of the suspension member or a portion of the suspension member (e.g., self-affixing tanged mesh) into a sacrospinous or iliococcygeus anchoring site; inserting the uterine manipulator through the cervix and securing it thereto; fastening the suspension member to the corners of the vaginal apex or placing the suspension member adjacent to the vaginal apex; applying gentle traction on the sutures or the self-affixing mesh; advancing the uterine manipulator to the anchoring site; removing the device; tying the sutures or adjusting the self-affixing mesh to the appropriate tension; and closing the vaginal incision.


In still another embodiment, the invention includes a suspension member, the suspension member includes at least one suture having an anchoring member at a first end and a free end for manipulation by a practitioner, wherein the suture is woven through the suspension member for providing accordion-type folds. In some embodiments, the suspension member is constructed of a self-affixing mesh material requiring passage of mesh arms rather than sutures through the pelvic tissue/anchoring site.


Advantageously, the device of the invention will introduce a minimally invasive, uterinesparing prolapse surgery that can be incorporated into mainstream gynecologic practice. The device can provide an effective, simple and reproducible uterine suspension technique for general gynecologic surgeons. The procedures described herein have the potential to attract countless women with uterine prolapse who would otherwise have avoided an operation, and increase the market of women choosing the described surgery for treatment of their prolapsed condition.


These and other aspects, features and advantages of the invention will be understood with reference to the drawing figures and detailed description herein, and will be realized by means of the various elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the brief description of the drawings and detailed description of the invention are exemplary and explanatory of some embodiments of the invention, and are not restrictive of the invention, as claimed.



FIG. 1 is a schematic illustration of various components that can be used in a uterine suspension procedure to treat, for example, a uterine prolapse. A suspension device 110 can include a body 112 having a uterine manipulator device 118 disposed at a proximal end of the body 112. The suspension device can be, for example, a suspension device 10 described in more detail with reference to FIG. 2. In some embodiments, the body 112 is substantially rigid and defines a lumen (not shown in FIG. I) extending between a proximal end and a distal end of the body 112. The uterine manipulator device 118 can include, for example, a prong 134 configured to be inserted through a cervix, and a clip 136, such as a tenaculum clip, with a sharp point configured to secure the uterine manipulator device 118 to the cervix during a uterine suspension procedure, as will be described in more detail below with reference to the uterine manipulator 18.


The suspension device 110 can be used to help secure a uterine suspension member 120 within a pelvic region P of a patient. A suspension member 120 can be formed, for example, with a mesh material and configured to be anchored on one end to a pelvic tissue T1 such as a sacrospinous ligament or a levator muscle, such as the iliococcygeus muscle, and on another end to a pelvic tissue T2 disposed on an opposite side of the uterus of the patient. Another portion of the suspension member 120 can be configured to be attached to a vaginal apex V of the patient. An example embodiment of a suspension member 20 is described in more detail below with reference to FIG. 2. An anchoring member 144 that includes a pair of winged portions (not shown in FIG. 1) can be releasably coupled to the uterine manipulator 118 of the suspension device 110 and inserted into a vagina of the patient using the suspension device 110. An example embodiment of an anchoring member 44 is described below with reference to FIG. 2. The anchoring member 144 can be released from the suspension device 120 and used to help secure the suspension member 120 within the pelvic region P of the patient. The suspension device 110 can also be used to move or manipulate the uterus during a uterine suspension procedure to place the uterus into a correct anatomical position.


With reference now to FIG. 2, an inter-vaginal uterine suspension device 10 for performing a vaginal hysteropexy is shown by way of an example embodiment. The uterine suspension device 10 includes a substantially rigid body 12 having a shaft 14 with a handle 16 at its distal end and a uterine manipulator portion 18 at its proximal end. Preferably, the handle 16 is an ergonomic handle, and those skilled in the art will understand that various handles can be employed without deviating from the scope of the present invention.


The substantially rigid body 12 is used to implant a suspension member 20 around the uterus so as to secure the uterus to a muscle or ligament in the deep pelvic area. The body 12 can be constructed of an inert and biocompatible material such as, for example, a metal such as titanium or stainless steel or a plastic, although those skilled in the art will understand that various materials can be employed without deviating from the scope of the present invention. The rigid body 12 can be reusable or it can be disposable. If the body is reusable, then the materials of construction are preferably autoclavable or otherwise capable of sterilization.


The suspension member 20 is configured generally in the shape of a “U” having a pair of arms 22 and 24. The suspension member 20 can be formed, for example, of polypropylene or prolene mesh, although those skilled in the art will understand that various other biocompatible and biologically inert materials can be used as well for the suspension member 20. Additionally, the suspension member 20 may not be a “mesh” but instead be a band of an inert and biologically compatible material.


At least one, and preferably two tensioning sutures 26 and 28 are woven into the suspension member 20 for providing a suspension member with an accordion-type design (or accordion-type folds). A first anchor 30 is located at the proximal end of the suture 26, and a second anchor 32 is located at the proximal end of the suture 28. The anchors 30 and 32 anchor or attach the sutures 26 and 28 to an anchoring site, which is typically a pelvic muscle or ligament. The distal ends of the pair of sutures 26 and 28 are woven into the suspension member 20 and pass through a lumen 29 through the shaft 14 and out of the body 12 of the device 10 near the handle 16 so that the practitioner can manipulate the sutures with one hand while gripping the handle 16 with the other hand to manipulate the uterus.


The uterine manipulator portion 18 can include a substantially rigid prong 34 for insertion through the cervix into the uterus, a tenaculum (or a tenaculum clip) 36 with a sharp point for securing the uterine manipulator to the cervix, and an anchoring member 44 having a pair of wings 38 and 40 for anchoring the suspension member 20 to the vagina, can be coupled to the uterine manipulator 18. The wings 38 and 40 can be constructed of a malleable, “shapememory” plastic, which allows for a comfortable fit into the vaginal fornices. Also, the wings 38 and 40 can each include at least one, and in some embodiments, a plurality of apertures 42 therein so that the practitioner can connect or suture the suspension member 20 to the vagina through the apertures. The wings 38 and 40 spread into the lateral corners of the vagina so that the suspension member 20 can be secured to the vagina.


In one embodiment, a method of performing a vaginal uterine suspension begins by administering anesthesia to the patient. For example, either a general anesthesia or an epidural anesthesia can be used. A practitioner makes an anterior or posterior vaginal incision, performs a standard anterior colporrhaphy dissection, and palpates the ischial spines bilaterally, all of which are generally well known to those skilled in the art. As the uterine suspension device 10 is inserted into the vagina, the practitioner inserts the suspension member 20 through the anterior (or posterior) vaginal incision. The ends of the suspension member 20, i.e., the sutures 26 and 28, are anchored in a pelvic muscle or ligament such that the suspension member generally surrounds the uterus. In some embodiments, the first suture 28 with anchor 32 is anchored into the sacrospinous ligament or the levator muscle (such as the iliococcygeus muscle) and the second suture 26 with anchor 30 is anchored into the sacrospinous or levator muscle on the opposite side, as depicted in FIG. 3. For example, the Capio® device manufactured by Boston Scientific can be used to place the sutures, although those skilled in the art will understand that various other suturing devices and techniques can be employed as well, including using a needle trocar to perforate the muscle or ligament and anchor the suture, or attach the suspension device 20 directly to the muscle. For example, the suspension device 20 can be formed with a mesh material that can be anchored directly to the tissue or muscle. Some iterations may involve fixation of mesh arms with no sutures/knot tying, by passing tension-free self-affixing mesh through the tissue or muscle.


The prong 34 of the uterine manipulator 18 is inserted through the cervix into the uterus and is fastened thereto with the tenaculum clip 36. In so doing, the wings 38 and 40 coupled to the device 10 are positioned into the lateral corners of the vaginal apex. The suspension member 20 is fastened to the corners of the vaginal apex by suturing the suspension member 20 to the inside of the vagina through the apertures 42 in the wings 38 and 40. For example, sutures can be placed 2 cm lateral to the midline on each side. Optionally, the practitioner can use bioabsorbable anchors or sutures to secure the suspension member 20 to the vagina. Also optionally, if an augmentation is planned, an anterior or posterior graft can be secured with the same anchors at the vaginal apical corners.


The practitioner applies gentle traction on the sutures 26 and 28 (i.e., pulling the sutures rearwardly from the device 10) while simultaneously slowly advancing the uterine manipulator 18 in a direction generally towards the anchoring site e.g., the sacrospinous ligament or the iliococcygeus muscle). In so doing, the cervix along with the uterus is pushed up while the suspension member 20 shortens because of its accordion design and recreates the cardinaluterosacral attachments between the vaginal apex and the pelvic sidewall. The practitioner removes the device 10, withdrawing it over the sutures 26 and 28, which are held at constant tension. The practitioner ties the sutures 26 and 28, without tension, leaving them inside the vaginal incision. The vagina is closed after completion of anterior compartment repair (i.e. colporrhaphy, graft placement).



FIG. 4 illustrates a method according to an embodiment of the invention. A method includes at 50 repositioning a uterus of a patient into a normal anatomic position. At 52, the uterus is supported in the normal anatomic position with a uterine suspension member secured to a vaginal apex of the patient. In some embodiments, the repositioning of the uterus includes at 54, advancing a uterine manipulator in a direction toward a selected portion of a pelvic tissue such that at least a portion of the uterus is moved upward. In some embodiments, the uterine suspension member is positioned across the vaginal apex and an end of the uterine suspension member is anchored or secured to a portion of pelvic tissue, and the uterine suspension member is also secured to the vaginal apex, at 56. In some embodiments, a first end of the uterine suspension member is secured to a first portion of pelvic tissue and a second end of the uterine suspension member is secured to a second portion of pelvic tissue, at 58. In some embodiments, an end of the uterine suspension member is secured to a sacrospinous ligament. In some embodiments, the uterine suspension member is positioned around the uterus and secured to a levator muscle.



FIG. 5 illustrates a method according to another embodiment of the invention. A method includes at 60 inserting at least a portion of a uterine suspension member through an anterior or posterior vaginal incision. An end of the suspension member is anchored to a selected portion of a pelvic tissue at 62. The pelvic tissue can be, for example, a sacrospinous ligament, or a levator muscle, such as an iliococcygeus muscle. In some embodiments, the anchoring an end of the suspension member includes anchoring an end of a suture coupled to the suspension member to the selected portion of the pelvic tissue.


At 64, at least a portion of the suspension member is attached to a vaginal apex. In some embodiments, the attaching the at least a portion of the suspension member to the vaginal apex includes at 66, coupling an anchoring member disposed within an interior of the vagina to the suspension member such that a portion of a wall of the vagina is disposed between the suspension member and the anchoring member. In some embodiments, the attaching at least a portion of the suspension member to the vaginal apex includes attaching the suspension member at a first corner of the vaginal apex and attaching the suspension member at a second corner of the vaginal apex. In some embodiments, the suspension member has a first end and a second end, and the second end of the suspension member is anchored to a second selected portion of a pelvic tissue on an opposite side of the uterus at 68.


At 70, a uterine manipulator can be optionally advanced in a direction toward the selected portion of tissue such that at least a portion of a uterus is moved upward. At 72, in some embodiments, simultaneously with the advancing the uterine manipulator, traction is applied to a suture coupled to the suspension member.


In some embodiments, a kit can be provided that includes at least one suspension member, such as suspension member 20, and a medical device, such as suspension device 10. The suspension member can have an end configured to be anchored to a pelvic tissue within a patient and a portion configured to be attached to a vaginal apex of the patient. The medical device can be used during a uterine suspension procedure to assist in securing the suspension member within a pelvic region of the patient. A kit can also include an anchoring member, such as anchoring member 44, configured to be disposed within an interior of a vagina of the patient and coupleable to the suspension member to help secure the suspension member to the vagina. A kit can also include at least one mesh or a graft to be used in a procedure such as a cystocele or rectocele augmentation.


CONCLUSION

While various embodiments of the invention have been described above, it should be understood that they have been presented by way of example only, and not limitation. Thus, the breadth and scope of the invention should not be limited by any of the above-described embodiments, but should be defined only in accordance with the following claims and their equivalents.


The previous description of the embodiments is provided to enable any person skilled in the art to make or use the invention. While the invention has been particularly shown and described with reference to embodiments thereof, it will be understood by those skilled in art that various changes in form and details may be made therein without departing from the spirit and scope of the invention.


For example, a variety of different suspension members 20 can be used in any of the uterine suspension procedures described herein. A suspension member can be a variety of different configurations, shapes and/or sizes and be formed with various different materials not specifically described. The suspension device 10 can include any combination or subcombination of the various features and components described herein. Further, other configurations for a suspension device can be used to perform the uterine suspension procedures described herein, while still remaining within the scope of the invention.

Claims
  • 1. A method, comprising: inserting at least a portion of a uterine suspension member through an anterior vaginal incision of a patient;positioning the uterine suspension member such that the uterine suspension member forms a “U” shape and generally surrounds a uterus of the patient;anchoring an end of the suspension member to a selected portion of a pelvic tissue, the anchoring including inserting a portion of the uterine suspension member through the pelvic tissue; andsecuring at least a portion of the suspension member to a vaginal apex.
  • 2. The method of claim 1, further comprising: advancing a uterine manipulator in a direction toward the selected portion of the pelvic tissue such that at least a portion of a uterus is moved upward.
  • 3. The method of claim 1, wherein the end of the suspension member is a first end, the selected portion of a pelvic tissue is a first selected portion of a pelvic tissue, the method further comprising: prior to the securing, anchoring a second end of the suspension member to a second selected portion of a pelvic tissue on an opposite side of a uterus.
  • 4. The method of claim 1, wherein the securing the at least a portion of the suspension member to the vaginal apex includes coupling an anchoring member disposed within an interior of the vagina to the suspension member such that a portion of a wall of the vagina is disposed between the suspension member and the anchoring member.
  • 5. The method of claim 1, wherein the securing the at least a portion of the suspension member to the vaginal apex, includes securing the suspension member at a first corner of the vaginal apex and securing the suspension member at a second corner of the vaginal apex.
  • 6. The method of claim 1, further comprising: advancing a uterine manipulator in a direction toward the selected portion of the pelvic tissue such that at least a portion of a uterus is moved upward; and simultaneously with the advancing the uterine manipulator, applying traction to a suture.
  • 7. The method of claim 1, wherein the pelvic tissue includes a sacrospinous ligament of the patient.
  • 8. The method of claim 1, wherein the inserting a portion of the uterine suspension member through the pelvic tissue includes inserting a self-affixing portion of the uterine suspension member through a sacrospinous ligament of the patient.
  • 9. The method of claim 1, wherein the inserting a portion of the uterine suspension member through the pelvic tissue includes inserting a self-affixing portion of the uterine suspension member through the pelvic tissue using a suturing device.
  • 10. The method of claim 1, wherein the inserting a portion of the uterine suspension member through the pelvic tissue includes using a suturing device to insert the portion of the uterine suspension member through the pelvic tissue.
  • 11. An apparatus, comprising: a body having a proximal end and a distal end, the proximal end of the body configured to be inserted into a vagina of a patient to assist in securing a uterine suspension member within a pelvic region of the patient,the body defining a lumen and a first opening on the distal end of the body and a second opening on the proximal end of the body, the first and second opening being in communication with the lumen,the lumen configured to receive a suture coupled to a suspension member that is disposed within a pelvic region of the patient through the second opening such that an end of the suture is disposed through the first opening and accessible outside the lumen; anda uterine manipulator disposed at the proximal end of the body, the uterine manipulator configured to be releasably coupled to a cervix of the patient during a uterine suspension procedure, the uterine manipulator having an anchoring member having a first wing portion and a second wing portion, the first wing portion defining an opening, the second wing portion defining an opening.
  • 12. The apparatus of claim 11, wherein the uterine manipulator includes a prong for insertion through the cervix and into a uterus of the patient, and a clip for securing the uterine manipulator to the cervix.
  • 13. The apparatus of claim 11, wherein the body is configured to releasably couple an anchoring member at the proximal end of the body such that the anchoring member can be released from the body at a location within an interior of the vagina to help secure a uterine suspension member to the vagina.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of, and claims priority to, U.S. patent application Ser. No. 11/535,901, filed on Sep. 27, 2006, entitled “APPARATUS AND METHOD FOR SUSPENDING A UTERUS,” which, in turn, claims priority to U.S. Provisional Application No. 60/721,366, filed on Sep. 28, 2005, entitled “APPARATUS AND METHOD FOR SUSPENDING A UTERUS,” both of which are incorporated by reference herein in their entirety.

US Referenced Citations (283)
Number Name Date Kind
669034 Manly Feb 1901 A
2687131 Raiche Aug 1954 A
3123077 Alcamo Mar 1964 A
4083369 Sinnreich Apr 1978 A
4324331 Ignasiak Apr 1982 A
4792336 Hlavacek et al. Dec 1988 A
4919667 Richmond Apr 1990 A
4979956 Silvestrini Dec 1990 A
4998912 Scarbrough et al. Mar 1991 A
5013292 Lemay May 1991 A
5082112 Dunklee Jan 1992 A
5112344 Petros May 1992 A
5149329 Richardson Sep 1992 A
5217466 Hasson Jun 1993 A
5217486 Rice et al. Jun 1993 A
5217494 Coggins et al. Jun 1993 A
5219359 McQuilkin Jun 1993 A
5263969 Phillips Nov 1993 A
5356432 Rutkow et al. Oct 1994 A
5362294 Seitzinger Nov 1994 A
5364408 Gordon Nov 1994 A
5383905 Golds et al. Jan 1995 A
5405359 Pierce Apr 1995 A
5425747 Brotz Jun 1995 A
5451235 Lock et al. Sep 1995 A
5458609 Gordon et al. Oct 1995 A
5458636 Brancato Oct 1995 A
5464409 Mohajer Nov 1995 A
5485917 Early Jan 1996 A
5527341 Gogolewski et al. Jun 1996 A
5534008 Acksel Jul 1996 A
5540704 Gordon et al. Jul 1996 A
5562689 Green et al. Oct 1996 A
5569283 Green et al. Oct 1996 A
5575800 Gordon Nov 1996 A
5578044 Gordon et al. Nov 1996 A
5584859 Brotz Dec 1996 A
5611515 Benderev et al. Mar 1997 A
5643311 Smith et al. Jul 1997 A
5662664 Gordon et al. Sep 1997 A
5683402 Cosgrove et al. Nov 1997 A
5700272 Gordon et al. Dec 1997 A
5702397 Goble et al. Dec 1997 A
5713910 Gordon et al. Feb 1998 A
5720761 Kaali Feb 1998 A
5741277 Gordon et al. Apr 1998 A
5741279 Gordon et al. Apr 1998 A
5741299 Rudt Apr 1998 A
5840011 Landgrebe et al. Nov 1998 A
5871488 Tovey et al. Feb 1999 A
5899909 Claren et al. May 1999 A
5922826 Kuze et al. Jul 1999 A
5931855 Buncke Aug 1999 A
5948001 Larsen Sep 1999 A
5976127 Lax Nov 1999 A
5988549 Hitomi et al. Nov 1999 A
6010447 Kardjian Jan 2000 A
6012580 Peters et al. Jan 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042536 Tihon et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6044847 Carter et al. Apr 2000 A
6048351 Gordon et al. Apr 2000 A
6096051 Kortenbach et al. Aug 2000 A
6102921 Zhu et al. Aug 2000 A
6195646 Grosh et al. Feb 2001 B1
6197036 Tripp et al. Mar 2001 B1
6200330 Benderev et al. Mar 2001 B1
6221005 Bruckner et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6273852 Lehe et al. Aug 2001 B1
6306079 Trabucco Oct 2001 B1
6322492 Kovac Nov 2001 B1
6328686 Kovac Dec 2001 B1
6346111 Gordon et al. Feb 2002 B1
6375662 Schmitt Apr 2002 B1
6382214 Raz et al. May 2002 B1
6406423 Scetbon Jun 2002 B1
6454778 Kortenbach Sep 2002 B2
6478727 Scetbon Nov 2002 B2
6491703 Ulmsten Dec 2002 B1
6502578 Raz et al. Jan 2003 B2
6506190 Walshe Jan 2003 B1
6530943 Hoepffner et al. Mar 2003 B1
6544273 Harari et al. Apr 2003 B1
6547800 Foerster et al. Apr 2003 B2
6551329 Kortenbach et al. Apr 2003 B1
6565580 Beretta May 2003 B1
6575897 Ory et al. Jun 2003 B1
6575998 Beyar Jun 2003 B2
6582443 Cabak et al. Jun 2003 B2
6592515 Thierfelder et al. Jul 2003 B2
6592610 Beyar et al. Jul 2003 B2
6595911 LoVuolo Jul 2003 B2
6596001 Stormby et al. Jul 2003 B2
6599235 Kovac Jul 2003 B2
6599310 Leung et al. Jul 2003 B2
6612977 Staskin et al. Sep 2003 B2
6638209 Landgrebe Oct 2003 B2
6638210 Berger Oct 2003 B2
6638211 Suslian et al. Oct 2003 B2
6638284 Rousseau et al. Oct 2003 B1
6641524 Kovac Nov 2003 B2
6641525 Rocheleau et al. Nov 2003 B2
6648899 Kalinski et al. Nov 2003 B2
6648921 Anderson et al. Nov 2003 B2
6652450 Neisz et al. Nov 2003 B2
6666817 Li Dec 2003 B2
6669706 Schmitt et al. Dec 2003 B2
6669735 Pelissier Dec 2003 B1
6673010 Skiba et al. Jan 2004 B2
6691711 Raz et al. Feb 2004 B2
6695855 Gaston Feb 2004 B1
6702827 Lund et al. Mar 2004 B1
6730110 Harari et al. May 2004 B1
6746455 Beyar et al. Jun 2004 B2
6752814 Gellman et al. Jun 2004 B2
6755781 Gellman Jun 2004 B2
6808487 Migliari Oct 2004 B2
6830052 Carter et al. Dec 2004 B2
6848152 Genova et al. Feb 2005 B2
6872227 Sump et al. Mar 2005 B2
6881184 Zappala Apr 2005 B2
6890338 Davis et al. May 2005 B1
6908425 Luscombe Jun 2005 B2
6911003 Anderson et al. Jun 2005 B2
6911034 Nobles et al. Jun 2005 B2
6932759 Kammerer et al. Aug 2005 B2
6936052 Gellman et al. Aug 2005 B2
6936054 Chu Aug 2005 B2
6936952 Takamine Aug 2005 B2
6946003 Wolowacz et al. Sep 2005 B1
6953428 Gellman et al. Oct 2005 B2
6960160 Browning Nov 2005 B2
6971986 Staskin et al. Dec 2005 B2
6986780 Rudnick et al. Jan 2006 B2
6991597 Gellman et al. Jan 2006 B2
7011688 Gryska et al. Mar 2006 B2
7025772 Gellman et al. Apr 2006 B2
7048682 Neisz et al. May 2006 B2
7056333 Walshe Jun 2006 B2
7070556 Anderson et al. Jul 2006 B2
7070558 Gellman et al. Jul 2006 B2
7083568 Neisz et al. Aug 2006 B2
7083637 Tannhauser Aug 2006 B1
7090686 Nobles et al. Aug 2006 B2
7094199 Petros et al. Aug 2006 B2
7112171 Rocheleau et al. Sep 2006 B2
7112210 Ulmsten et al. Sep 2006 B2
7122039 Chu Oct 2006 B2
7131943 Kammerer Nov 2006 B2
7131944 Jacquetin Nov 2006 B2
7198597 Siegel et al. Apr 2007 B2
7204801 Grocela Apr 2007 B2
7204802 De Leval Apr 2007 B2
7223229 Inman et al. May 2007 B2
7226407 Kammerer et al. Jun 2007 B2
7226408 Harai et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7235043 Gellman et al. Jun 2007 B2
7244260 Koseki Jul 2007 B2
7244759 Muller et al. Jul 2007 B2
7267645 Anderson et al. Sep 2007 B2
7291104 Neisz et al. Nov 2007 B2
7351197 Montpetit et al. Apr 2008 B2
7361138 Wagner et al. Apr 2008 B2
7364541 Chu et al. Apr 2008 B2
7402133 Chu et al. Jul 2008 B2
7413540 Gellman et al. Aug 2008 B2
7527588 Zaddem et al. May 2009 B2
8128552 O'Donnell Mar 2012 B2
8911348 Goldberg et al. Dec 2014 B2
20010023356 Raz et al. Sep 2001 A1
20010049467 Lehe et al. Dec 2001 A1
20020010457 Duchon et al. Jan 2002 A1
20020028980 Thierfelder et al. Mar 2002 A1
20020099259 Anderson et al. Jul 2002 A1
20020128670 Ulmsten et al. Sep 2002 A1
20020133236 Rousseau Sep 2002 A1
20020143234 LoVuolo Oct 2002 A1
20020147382 Neisz et al. Oct 2002 A1
20020151909 Gellman et al. Oct 2002 A1
20020156489 Gellman et al. Oct 2002 A1
20030009181 Gellman et al. Jan 2003 A1
20030023138 Luscombe Jan 2003 A1
20030023250 Watschke et al. Jan 2003 A1
20030050530 Neisz et al. Mar 2003 A1
20030055313 Anderson et al. Mar 2003 A1
20030078604 Walshe Apr 2003 A1
20030125715 Kuehn et al. Jul 2003 A1
20030149334 Ulmsten et al. Aug 2003 A1
20030176762 Kammerer Sep 2003 A1
20030191360 Browning Oct 2003 A1
20030208208 Chu Nov 2003 A1
20030220538 Jacquetin Nov 2003 A1
20030225424 Benderev Dec 2003 A1
20030233107 Gellman et al. Dec 2003 A1
20030233108 Gellman et al. Dec 2003 A1
20040006353 Bosley et al. Jan 2004 A1
20040015048 Neisz et al. Jan 2004 A1
20040015177 Chu Jan 2004 A1
20040034372 Chu Feb 2004 A1
20040039246 Gellman et al. Feb 2004 A1
20040039453 Anderson et al. Feb 2004 A1
20040059293 Chu et al. Mar 2004 A1
20040068159 Neisz et al. Apr 2004 A1
20040073234 Chu et al. Apr 2004 A1
20040087970 Chu et al. May 2004 A1
20040106847 Benderev Jun 2004 A1
20040116944 Chu et al. Jun 2004 A1
20040133217 Watschke Jul 2004 A1
20040138747 Kaladelfos Jul 2004 A1
20040181243 Chu et al. Sep 2004 A1
20040186515 Rosenblatt Sep 2004 A1
20040225181 Chu et al. Nov 2004 A1
20040230206 Gellman et al. Nov 2004 A1
20040231678 Fierro Nov 2004 A1
20040236356 Rioux et al. Nov 2004 A1
20040249397 Delorme et al. Dec 2004 A1
20040249473 Delorme et al. Dec 2004 A1
20050004427 Cervigni Jan 2005 A1
20050004576 Benderev Jan 2005 A1
20050038451 Rao et al. Feb 2005 A1
20050038452 Chu Feb 2005 A1
20050075660 Chu et al. Apr 2005 A1
20050080317 Merade Apr 2005 A1
20050090706 Gellman et al. Apr 2005 A1
20050096499 Li et al. May 2005 A1
20050101834 Merade May 2005 A1
20050107805 Bouffier et al. May 2005 A1
20050131391 Chu et al. Jun 2005 A1
20050131392 Chu et al. Jun 2005 A1
20050131393 Chu et al. Jun 2005 A1
20050177022 Chu et al. Aug 2005 A1
20050192600 Nicolo et al. Sep 2005 A1
20050222589 Chu Oct 2005 A1
20050222591 Gingras et al. Oct 2005 A1
20050234291 Gingras Oct 2005 A1
20050245787 Cox et al. Nov 2005 A1
20050250977 Montpetit et al. Nov 2005 A1
20050250978 Kammerer Nov 2005 A1
20050256366 Chu Nov 2005 A1
20050256530 Petros Nov 2005 A1
20050261545 Gellman et al. Nov 2005 A1
20050261547 Bouffier Nov 2005 A1
20050277807 MacLean et al. Dec 2005 A1
20050278037 Delorme et al. Dec 2005 A1
20060015001 Staskin et al. Jan 2006 A1
20060025649 Smith et al. Feb 2006 A1
20060025783 Smith et al. Feb 2006 A1
20060041185 Browning Feb 2006 A1
20060041263 Chu et al. Feb 2006 A1
20060052801 Dreyfuss et al. Mar 2006 A1
20060058574 Priewe et al. Mar 2006 A1
20060058575 Zaddem et al. Mar 2006 A1
20060069301 Neisz et al. Mar 2006 A1
20060089524 Chu Apr 2006 A1
20060089525 Mamo et al. Apr 2006 A1
20060122457 Kovac et al. Jun 2006 A1
20060173237 Jacquetin Aug 2006 A1
20060205995 Browning Sep 2006 A1
20060211911 Jao et al. Sep 2006 A1
20060229493 Weiser et al. Oct 2006 A1
20060229596 Weiser et al. Oct 2006 A1
20060264698 Kondonis et al. Nov 2006 A1
20070043255 O'Donnell Feb 2007 A1
20070055095 Chu et al. Mar 2007 A1
20070161849 Goldberg Jul 2007 A1
20070173864 Chu Jul 2007 A1
20070270890 Miller Nov 2007 A1
20070276358 Barzell et al. Nov 2007 A1
20080177132 Alinsod et al. Jul 2008 A1
20080234543 Goldwasser Sep 2008 A1
20090171142 Chu Jul 2009 A1
20090171143 Chu et al. Jul 2009 A1
20100130814 Dubernard May 2010 A1
20100152530 Timmer et al. Jun 2010 A1
20110112357 Chapman et al. May 2011 A1
20120136324 Hanuka et al. May 2012 A1
20130066145 Fairneny et al. Mar 2013 A1
20150094527 Goldberg et al. Apr 2015 A1
Foreign Referenced Citations (63)
Number Date Country
10056169 Jun 2002 DE
0088714 Sep 1983 EP
0141589 May 1985 EP
0299158 Jan 1989 EP
0362146 Apr 1990 EP
0412664 Feb 1991 EP
0567130 Oct 1993 EP
0774240 May 1997 EP
1201189 May 2002 EP
1508305 Feb 2005 EP
1520554 Apr 2005 EP
1609439 Dec 2005 EP
1933786 Jun 2008 EP
2617385 Jul 2013 EP
1998711 Dec 2013 EP
2785521 May 2000 FR
2852817 Oct 2004 FR
2852818 Oct 2004 FR
2871365 Dec 2005 FR
670349 Apr 1952 GB
06114067 Apr 1994 JP
08117239 May 1996 JP
PA04008407 Dec 2005 MX
9609796 Apr 1996 WO
9639948 Dec 1996 WO
9835616 Aug 1998 WO
9835632 Aug 1998 WO
9843545 Oct 1998 WO
9937216 Jul 1999 WO
0009039 Feb 2000 WO
0074613 Dec 2000 WO
0074594 Dec 2000 WO
0106951 Feb 2001 WO
0152135 Jul 2001 WO
0231681 Apr 2002 WO
0232284 Apr 2002 WO
0238079 May 2002 WO
02058563 Aug 2002 WO
02062237 Aug 2002 WO
02078571 Oct 2002 WO
03068107 Aug 2003 WO
03073960 Sep 2003 WO
03092546 Nov 2003 WO
03096928 Nov 2003 WO
03096929 Nov 2003 WO
2004001619 Dec 2003 WO
2004012626 Feb 2004 WO
2004016196 Feb 2004 WO
2004091442 Oct 2004 WO
2004091443 Oct 2004 WO
2005051204 Jun 2005 WO
2005122721 Dec 2005 WO
2005122954 Dec 2005 WO
2006046950 May 2006 WO
2007014240 Feb 2007 WO
2007016698 Feb 2007 WO
2007019374 Feb 2007 WO
2007014240 Feb 2007 WO
2007016698 Feb 2007 WO
2007038589 Apr 2007 WO
2007059199 May 2007 WO
2007087132 Aug 2007 WO
2007087132 Aug 2007 WO
Non-Patent Literature Citations (76)
Entry
Non-Final Office Action for U.S. Appl. No. 11/686,683, mailed on Jul. 8, 2009, 13 pages.
Final Office Action for U.S. Appl. No. 11/686,683, mailed on Jan. 19, 2010, 15 pages.
Non-Final Office Action for U.S. Appl. No. 11/331,777, mailed on Apr. 21, 2008, 11 pages.
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Oct. 14, 2008, 15 pages.
Non-Final Office Action for U.S. Appl. No. 11/331,777, mailed on May 8, 2009, 14 pages.
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Dec. 8, 2009, 16 pages.
Advisory Action for U.S. Appl. No. 11/331,777, mailed on Mar. 10, 2009, 4 pages.
Advisory Action for U.S. Appl. No. 11/331,777, mailed on Feb. 17, 2010, 4 pages.
Non-Final Office Action for U.S. Appl. No. 11/493,148, mailed on Sep. 24, 2008, 12 pages.
Non-Final Office Action for U.S. Appl. No. 11/493,148, mailed on Jun. 5, 2009, 14 pages.
Final Office Action for U.S. Appl. No. 11/493,148, mailed on Dec. 17, 2009, 13 pages.
Non-Final Office Action for U.S. Appl. No. 11/493,148, mailed on Mar. 25, 2010, 14 pages.
Final Office Action for U.S. Appl. No. 11/493,148, mailed on Jul. 12, 2010, 14 pages.
Notice of Allowance for U.S. Appl. No. 11/493,148, mailed on Sep. 30, 2010, 6 pages.
European Office Action for EP Patent Application No. 07716311.1, mailed on Dec. 8, 2009, 3 pages.
Notice of Allowance for U.S. Appl. No. 11/535,901, mailed on Sep. 21, 2010, 26 pages.
“Capio® CL Transvaginal Suture Capturing Device”, The Capio CL Transvaginal Suture Capturing Device allows for a transvaginal suture fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, printed on Apr. 7, 2006, 2 pages.
“Capio® CL Transvaginal Suture Capturing Device”, Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures, Boston Scientific, 2000, 4 pages.
“Capio® Open Access and Standard Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, printed on Apr. 7, 2006, 2 pages.
“Capio® RP Suture Device”, Boston Scientific, printed on Apr. 7, 2006, 1 page.
“Capio® RP Suture Device”, The Capio RP Suturing Device is designed to assist with anastomosis after a radical prostatectomy, undated,1 page.
“Capio® Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, 2005, 4 pages.
International Search Report for PCT Application No. PCT/FR2004/000765, mailed on Dec. 28, 2004, 10 pages.
International Search Report and Written Opinion of the International Searching Authority received for PCT Application No. PCT/US2007/000190, mailed on Jul. 3, 2007, 9 pages.
International Search Report received for PCT Application No. PCT/AU2004/001674, mailed on Dec. 21, 2004, 3 pages.
International Search Report received for PCT Application No. PCT/FR2004/000766, mailed on Aug. 11, 2004, 9 pages.
International search Report received for PCT Application No. PCT/US2001/031234, mailed on Dec. 14, 2001, 1 page.
International Search Report received for PCT Application No. PCT/US2001/30033, mailed on May 10, 2002, 1 page.
International search report received for PCT Application No. PCT/US2006/028963, mailed on Dec. 6, 2006, 3 pages.
International Search Report received for PCT Application No. PCT/US2007/000190, mailed on Jul. 3, 2007, 5 pages.
International Search Report received for PCT Application No. PCT/US2005/021267, mailed on Nov. 30, 2005, 6 pages.
European Search Report received for EP Patent Application No. EP 01117717, mailed on Apr. 18, 2007, 5 pages.
European Search Report received for EP Patent Application No. EP 90307704, mailed on Apr. 18, 2007, 1 page.
Search report received for French Patent Application No. FR0406352, mailed on Jan. 13, 2005, 3 pages.
European Search Report received for EP Patent Application No. EP 05356101, mailed on Nov. 1, 2005, 2 pages.
Search report received for French Patent Application No. FR 0303893, mailed on Jan. 21, 2004, 2 pages.
Search report received for French Patent Application No. FR 0303895, mailed on Jan. 21, 2004, 3 pages.
International Search Report received for PCT Application No. PCT/US1998/03066, mailed on May 28, 1998, 2 pages.
International Search report received for PCT Application No. PCT/US2004/035329, mailed on Jul. 7, 2005, 7 pages.
Notification Concerning Transmittal of Copy of International Preliminary Report on Patentability (Chapter I of the Patent Cooperation Treaty) issued in corresponding International Application No. PCT/US2007/000190, mailed on Jul. 24, 2008.
International Search Report received for PCT Application No. PCT/US2007/064079 mailed on Aug. 28, 2007, 4 pages.
Final Office Action received for U.S. Appl. No. 11/535,901, mailed on Jan. 29, 2009, 22 pages.
Non-Final Office Action received for U.S. Appl. No. 11/535,901, mailed on Jun. 9, 2009, 22 pages.
Leron, E. et al., “Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse”, British Journal of Obstetrics and Gynaecology, 108.3, 2001, pp. 629-633.
Final Office Action for U.S. Appl. No. 11/686,683, mailed Nov. 5, 2012, 32 pages.
Non-Final Office Action for U.S. Appl. No. 11/686,683, mailed Aug. 13, 2013, 26 pages.
Non-Final Office Action for U.S. Appl. No. 13/218,840, mailed Jun. 7, 2013, 11 pages.
Non-Final Office Action Response for U.S. Appl. No. 13/218,840, filed Sep. 3, 2013, 9 pages.
Final Office Action Response for U.S. Appl. No. 11/686,683, filed Feb. 5, 2013, 17 pages.
Pohl, et al, “Bilateral Transvaginal Sacrospinous Colpopexy: Preliminary Experience”, 23rd Annual Meeting of the Society of Gynecologic Surgeons, Feb. 24-26, 1997, 7 pages.
Shah, et al, “Short-Term Outcome Analysis of Total Pelvic Reconstruction With Mesh: The Vaginal Approach”, The Journal of Urology, vol. 171, Jan. 2004, pp. 261-263.
Hardiman, et al, “Sacrospinous Vault Suspension and Abdonimal Colposacropexy: Success Rates and Complications”, Section of Urogynecology, Department of Obstetrics and Gynecology, University of Toronto, Mount Sinai Hospital, Sep. 18, 1995, 5 pages.
Non Final Office Action for U.S. Appl. No. 11/331,777, mailed on Dec. 6, 2013, 18 pages.
Response to Non Final Office Action for U.S. Appl. No. 11/331,777, filed Mar. 6, 2014, 8 pages.
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Apr. 14, 2014, 18 pages.
Final Office Action for U.S. Appl. No. 13/218,840, mailed on Dec. 24, 2013, 11 pages.
Response to Final Office Action for U.S. Appl. No. 13/218,840, filed Mar. 24, 2014, 12 pages.
Notice of Allowance for U.S. Appl. No. 13/218,840, mailed on May 1, 2014, 7 pages.
Final Office Action for U.S. Appl. No. 11/686,683, mailed on Feb. 25, 2014, 29 pages.
Response to Non Final Office Action for U.S. Appl. No. 11/686,683, filed Nov. 13, 2013, 13 pages.
Response to Office Action for European Patent Application No. 07758616.2, filed on Oct. 17, 2011, 31 pages.
Office Action for European Patent Application No. 06815573.8, mailed on Nov. 15, 2013, 3 pages.
International Preliminary Report on Patentability for PCT Application No. PCT/US2011/49753, mailed on Mar. 14, 2013, 9 pages.
Extended European Search Report for EP Application No. 13164488.2, mailed Jul. 31, 2014, 6 pages.
Non-Final Office Action for U.S. Appl. No. 13/606,883, mailed Aug. 1, 2014, 18 pages.
Notice of Allowance for U.S. Appl. No. 13/218,840, mailed Aug. 15, 2014, 7 pages.
Non-Final Office Action for U.S. Appl. No. 11/686,683, mailed Jun. 17, 2014, 31 pages.
Response to Final Office Action for U.S. Appl. No. 11/686,683, filed May 23, 2014, 15 pages.
Response to Final Office Action for U.S. Appl. No. 11/331,777, filed Jul. 11, 2014, 13 pages.
Non-Final Office Action for U.S. Appl. No. 11/331,777, dated Sep. 29, 2014, 19 pages.
Response to Non-Final Office Action for U.S. Appl. No. 11/331,777, filed Dec. 26, 2014, 7 pages.
Final Office Action for U.S. Appl. No. 11/331,777, mailed on Mar. 3, 2015, 14 pages.
Final Office Action for U.S. Appl. No. 11/686,683, mailed on Dec. 23, 2014, 18 pages.
Response to Final Office Action for U.S. Appl. No. 11/686,683, filed Feb. 23, 2015, 12 pages.
Notice of Allowance for U.S. Appl. No. 11/686,683, mailed on Mar. 13, 2015, 7 pages.
Final Office Action for U.S. Appl. No. 13/606,883, mailed on Mar. 30, 2015, 23 pages.
Related Publications (1)
Number Date Country
20110098527 A1 Apr 2011 US
Provisional Applications (1)
Number Date Country
60721366 Sep 2005 US
Continuations (1)
Number Date Country
Parent 11535901 Sep 2006 US
Child 12983666 US